JPH10210982A5 - - Google Patents

Info

Publication number
JPH10210982A5
JPH10210982A5 JP1997031505A JP3150597A JPH10210982A5 JP H10210982 A5 JPH10210982 A5 JP H10210982A5 JP 1997031505 A JP1997031505 A JP 1997031505A JP 3150597 A JP3150597 A JP 3150597A JP H10210982 A5 JPH10210982 A5 JP H10210982A5
Authority
JP
Japan
Prior art keywords
protein
salt
seq
partial peptide
ability
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP1997031505A
Other languages
English (en)
Japanese (ja)
Other versions
JPH10210982A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP9031505A priority Critical patent/JPH10210982A/ja
Priority claimed from JP9031505A external-priority patent/JPH10210982A/ja
Publication of JPH10210982A publication Critical patent/JPH10210982A/ja
Publication of JPH10210982A5 publication Critical patent/JPH10210982A5/ja
Pending legal-status Critical Current

Links

JP9031505A 1997-01-31 1997-01-31 新規なタンパク質 Pending JPH10210982A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP9031505A JPH10210982A (ja) 1997-01-31 1997-01-31 新規なタンパク質

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP9031505A JPH10210982A (ja) 1997-01-31 1997-01-31 新規なタンパク質

Publications (2)

Publication Number Publication Date
JPH10210982A JPH10210982A (ja) 1998-08-11
JPH10210982A5 true JPH10210982A5 (https=) 2004-12-24

Family

ID=12333090

Family Applications (1)

Application Number Title Priority Date Filing Date
JP9031505A Pending JPH10210982A (ja) 1997-01-31 1997-01-31 新規なタンパク質

Country Status (1)

Country Link
JP (1) JPH10210982A (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5999199A (en) * 1998-09-29 2000-04-17 Kyowa Hakko Kogyo Co. Ltd. Novel antibodies, drugs containing these antibodies and methods for screening compounds by using these antibodies
US7071164B2 (en) 2001-08-16 2006-07-04 Kimberly-Clark Worldwide, Inc. Anti-cancer and wound healing compounds
US6906036B2 (en) 2001-08-16 2005-06-14 Kimberly-Clark Worldwide, Inc. Anti-aging and wound healing compounds
US7094754B2 (en) 2001-08-16 2006-08-22 Kimberly-Clark Worldwide, Inc. Anti-aging and wound healing compounds
US7186693B2 (en) 2001-08-16 2007-03-06 Kimberly - Clark Worldwide, Inc. Metalloproteinase inhibitors for wound healing
US7148194B2 (en) 2002-12-30 2006-12-12 Kimberly-Clark Worldwide, Inc. Method to increase fibronectin
DE10303974A1 (de) 2003-01-31 2004-08-05 Abbott Gmbh & Co. Kg Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung
US7189700B2 (en) 2003-06-20 2007-03-13 Kimberly-Clark Worldwide, Inc. Anti-chrondrosarcoma compounds
HRP20140240T4 (hr) 2005-11-30 2017-02-24 Abbvie Inc. Monoklonalna antitijela protiv amiloidnih beta proteina i njihova upotreba
US8691224B2 (en) 2005-11-30 2014-04-08 Abbvie Inc. Anti-Aβ globulomer 5F7 antibodies
US8455626B2 (en) 2006-11-30 2013-06-04 Abbott Laboratories Aβ conformer selective anti-aβ globulomer monoclonal antibodies
US8895004B2 (en) 2007-02-27 2014-11-25 AbbVie Deutschland GmbH & Co. KG Method for the treatment of amyloidoses
TWI419974B (zh) * 2008-10-27 2013-12-21 Qiagen Gaithersburg Inc 於自動平台上之快速結果雜交捕捉法
US8987419B2 (en) 2010-04-15 2015-03-24 AbbVie Deutschland GmbH & Co. KG Amyloid-beta binding proteins
EP3533803B1 (en) 2010-08-14 2021-10-27 AbbVie Inc. Anti-amyloid-beta antibodies

Similar Documents

Publication Publication Date Title
JPH10210982A5 (https=)
Basilion et al. The iron-responsive element-binding protein: localization of the RNA-binding site to the aconitase active-site cleft.
Collier et al. H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen.
Várallyay et al. Two mutations in rat trypsin confer resistance against autolysis
Berry et al. A distinct member of the aspartic proteinase gene family from the human malaria parasite Plasmodium falciparum
JP3155984B2 (ja) タンパク質の安定化のための金属イオン結合部位における静電的相互作用の操作
US5081584A (en) Computer-assisted design of anti-peptides based on the amino acid sequence of a target peptide
RU2003112700A (ru) Гены новых сериновых протеаз, родственных dppiv
Gallinari et al. Modulation of hepatitis C virus NS3 protease and helicase activities through the interaction with NS4A
Bardwell et al. Yeast DNA recombination and repair proteins Rad 1 and Radio constitute a complex in vivo mediated by localized hydrophobic domains
Dolence et al. Studies with recombinant Saccharomyces cerevisiae CaaX prenyl protease Rce1p
Toma et al. Grafting of a calcium-binding loop of thermolysin to Bacillus subtilis neutral protease
AU5184090A (en) Matrix metalloproteinase peptides: role in diagnosis and therapy
Slavin et al. Dephosphorylation of cyst wall proteins by a secreted lysosomal acid phosphatase is essential for excystation of Giardia lamblia
US20030124529A1 (en) Pregnancy-associated plasma protein-A2 (PAPP-A2)
JPH10501962A (ja) マトリックス金属プロテアーゼのｄｎａ配列、その調製および使用
JP4383170B2 (ja) ヒストン脱アセチル化酵素９
Hudáky et al. The differential specificity of chymotrypsin A and B is determined by amino acid 226
CA2221409A1 (en) Mch2, an apoptotic cysteine protease, and compositions for making and methods of using the same
CA2428438A1 (en) Eukaryotic cell division genes and their use in diagnosis and treatment of proliferative diseases
US7718763B2 (en) Substrate polyeptides for von Willebrand factor cleaving protease ADAMTS-13
NO20010300D0 (no) Nye fremgangsmåter for identifisering av ligand og målbiomolekyler
US20090318342A1 (en) Compounds
Aki et al. cDNA cloning of rat proteasome subunit RC1, a homologue of RING10 located in the human MHC class II region
Joshi et al. Differential affinity labeling of the two subunits of the homodimeric animal fatty acid synthase allows isolation of heterodimers consisting of subunits that have been independently modified